Grants for State governments - Federal

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

The overarching goals of this study are 1) to update oil spill rates of OCS platforms, OCS pipelines, and U.S. barges, 2) to obtain oil spill information for BOEMs Offshore Environmental Cost Model (OECM), 3) to analyze oil spill trend and casual factors. Having updated oil spill and oil spill occurrence rate data is critically important to analyze the potential risk and consequence of OCS oil spills, investigate causal factors contributing to the occurrence, size or frequency of oil spills, enhance oil-spill response planning, and target future regulatory reform to better manage risk.Specific objectives are:Compilation of oil spill data and QA/QC of the dataExamination of historical spill occurrences and of volume of oil handledAnalysis of other potential exposure variablesEstimate spill occurrence rates and normalize these rates based on number of spills per volume handled and other potential exposure variablesAnalyses on oil spill trend and casual factorsProvide information for OECM modelPrepare a 508 compliant report according to BOEMs specifications.

The United States Department of Agricultures (USDA) Animal and Plant Health Inspection Service (APHIS) Veterinary Services (VS) is announcing the availability of cooperative agreement funding to carry out the Antimicrobial Resistance Dashboard (AMR Dashboard) as described in the U.S. House of Representatives Report for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, 2021. Through public-private partnerships, USDA APHIS will develop and utilize antimicrobial resistance dashboard tools to improve access to information on antimicrobial resistance in domesticated animals, including livestock, poultry, and companion animals. All antimicrobial resistance dashboard tools developed will provide data protections similar to the Confidential Information Protection and Statistical Efficiency Act. Once created, the antimicrobial resistance dashboard tools will be used to monitor trends in antimicrobial resistance patterns, detect emerging resistance profiles, and better understand relationships between antimicrobial use and animal health management practices and antimicrobial resistance. Additional details about the program and this funding opportunity, including additional information for applicants, are available at USDA APHIS One Health Funding Opportunities.

This funding opportunity provides financial support to U.S. public entities for planning and developing regional infrastructure projects, particularly in underserved and rural communities, to enhance project delivery and financing strategies.

This funding opportunity supports community projects in New England that aim to reduce environmental risks and improve public health, particularly for vulnerable populations such as children, the elderly, and those in environmental justice areas.

This funding opportunity supports collaborations between academic institutions and industry to develop innovative technologies that improve disease diagnosis, treatment, and management, particularly for underserved populations.

This funding opportunity provides financial support to organizations and consortia in the Gulf Coast Region for establishing research centers focused on coastal sustainability, fisheries, offshore energy, economic development, and environmental monitoring.

Workforce Innovation and Opportunity Act (WIOA) Wagner-Peyser Act Employment Service (ES) Allotments for Program Year (PY) 2024. States should e-mail all submission questions to Janice Sheelor, Grants Management Specialist, at [email protected]. The email must reference the specific Funding Opportunity Number, and include a contact name, email address, and phone number.

This funding opportunity supports research into how certain diabetes medications may influence cancer risk, encouraging studies that explore the underlying biological mechanisms involved.

This funding opportunity provides financial support to organizations working to combat domestic violence, dating violence, sexual assault, and stalking in rural communities across the U.S.

This funding opportunity is designed to help organizations acquire and assess commercial satellite imagery to improve flood monitoring and response capabilities in Alaskan communities affected by climate change.

This grant provides funding for innovative research using invasive brain recording and stimulation techniques in humans to improve understanding of the neural circuits involved in mental health disorders.

The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support, and increased freedom and flexibility, to Program Directors (PDs)/Principal Investigators (PIs), to allow them to redirect their time away from the administrative burden of writing and managing multiple grant applications and towards engaging in the lab. This RPA affords investigators at most career stages the opportunity to advance their long-term research goals, rigorously explore exciting research opportunities, and mentor students and postdoctorates, which support and align with the mission of NINDS. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a level commensurate with a PD/PIs recent NINDS support (Part 2, Section II). This funding stability will provide eligible investigators increased security, allowing them to undertake research projects that require a longer timeframe or to embark upon research that breaks new ground. Research activities outside of the NINDS mission, or traditionally supported by another NIH Institute or Center, will not be considered through this program. Benefits of the RPA include: A more stable funding environment, facilitating the pursuit of longer-term research goals; Flexible funding, enabling investigators to pursue research opportunities as they arise, not tied to specific aims; Reduced time spent writing grant applications and managing multiple grant awards, allowing investigators to spend more time conducting and overseeing research; More time for PDs/PIs to mentor and foster a diverse workforce in their laboratories. NINDS is committed to enhancing the diversity and inclusiveness of the neuroscience workforce. A diverse NIH-supported scientific workforce, including individuals from underrepresented groups, fosters scientific innovation, enhances global competitiveness, contributes to robust learning environments, and improves the quality of the research. See the Notice of NIH

This funding opportunity supports researchers conducting observational studies to improve understanding and treatment of musculoskeletal, rheumatic, and skin diseases, with a focus on patient outcomes and disease progression.

The Administration for Children and Families (ACF) is funding a cooperative agreement to sponsor the Child Development Research Fellowship that gives child development professionals from across the national academic research community the opportunity to experience policy research relevant to programs serving low-income children and families. This award is for an organization to lead the Child Development Research Fellowship Program. The organization must be a Professional Membership Organization for researchers who can support the Child Development Research Fellowship Program. A Professional Membership Organization aims to support individuals professionally and aid them in progressing within their career/profession. The goal of the fellowship program is to expose researchers to policy environments, particularly at the federal level, whereby they gain skills and expertise for policy-relevant research. The program is intended to stimulate the fellows knowledge of child development research and evaluation, particularly regarding services for low-income children and families, and to inform their process of developing long-term, policy-relevant research and evaluation agendas. The public will benefit from the increased availability of researchers highly skilled and experienced in policy and program relevant research and evaluation. Fellows will engage on a full-time basis for a period of 1 year (with a possible second or third year at the discretion of the award recipient and depending on funding availability). Fellows will be exposed to the broader child development policy environment, particularly at the federal level, and to the policy research community through activities organized and conducted by the award recipient. Fellows will learn extensively about ACF and our programs that serve young children and their families. The cooperative agreement will require active partnership between the successful applicant and Office of Planning, Research and Evaluation (OPRE).For more information about OPRE, see http://www.acf.hhs.gov/opre . Please subscribe to this forecast at grants.gov to receive notification of any updates.

This funding opportunity is designed to support states, public agencies, and Amtrak in improving and expanding intercity passenger rail services across the U.S., excluding the Northeast Corridor, by enhancing infrastructure and performance.

The Office of Refugee Resettlement (ORR), within the Administration for Children and Families (ACF), announces the availability of funds for the National Refugee Leadership and Lived Experience Council (NRLLEC) Program. The NRLLEC is a new program funded by the Office of Refugee Resettlement (ORR) that designs, implements, evaluates, and promotes national-level councils consisting of refugees and other ORR-eligible populations who have resettled into communities throughout the United States within the last five years. The NRLLEC Program will facilitate a National Young Adult Leadership Council comprised of members ages 18 to 24 every year for three years, as well as two additional councils with thematic focus to be determined in consultation with ORR. The NRLLEC Program will design, implement, evaluate, and promote five councils during the three-year project period. The programs primary goal is to positively impact the lives of council members and their refugee and larger communities by building council members capacity to serve as leaders. In addition, ORR recognizes that its engagement with these groups will enhance its ability to gather information from individual members firsthand about their lived experiences integrating into the United States. This will help inform ORR and its recipient network about how to best meet refugee needs through enhancing or changing ORR guidance, programming, and future councils. The NRLLEC Program will foster inclusivity, with council members attuned to the diversity, demographics, needs, and viewpoints of ORRs eligible population (https://www.acf.hhs.gov/orr/programs/refugees/factsheets). The NRLLEC Program will not seek consensus advice from council members.

The Centers for Medicare Medicaid Services (CMS), through its Center for Medicare and Medicaid Innovation, is soliciting applications for the Transforming Maternal Health (TMaH) Model. This is a voluntary, 10-year service delivery and payment model designed to improve maternal health care outcomes for people enrolled in Medicaid and the Children's Health Insurance Program (CHIP). The TMaH Model will test whether targeted technical (TA) assistance, coupled with payment and delivery system reforms, can drive a whole-person care-delivery approach to pregnancy, childbirth, and postpartum care while reducing Medicaid and CHIP program expenditures. CMS will select up to 15 state Medicaid agencies (SMAs or Recipients) to participate in the TMaH Model. Up to $17 million dollars in Cooperative Agreement funding will be available to each selected Recipient over the course of the 10-year period of performance for a total of up to $255M investment. CMS will evaluate the following: the TMaH Models impact on rates of lower c-risk cesarean section (c-section), severe maternal morbidity (SMM), incidence of low birthweight infants, changes in experience of care for pregnant and birthing people, and changes in Medicaid and CHIP program expenditures. The TMaH Model aims to improve maternal and child health outcomes while reducing Medicaid and CHIP program expenditures for maternal care through reduced spending on high-cost procedures such as c-sections for low-risk beneficiaries.

This funding opportunity is designed to establish a center that will coordinate and advance research on whole person health by integrating diverse biomedical knowledge and fostering collaboration among researchers.

This funding opportunity supports researchers with active NCI U01 awards who want to integrate innovative cancer research technologies to improve their studies and advance cancer prevention, detection, diagnosis, and treatment.